scorecardresearch
Add as a preferred source on Google
Saturday, February 28, 2026
TopicIndian pharmaceutical

Topic: Indian pharmaceutical

Chhindwara’s Coldrif deaths show India’s dangerous irony—pharmacy of the world, failing at home

India’s pharmaceutical sector is valued at $50 billion. It has built its reputation on affordability and accessibility. The deaths in Chhindwara tell a different story.

Trump’s 100% pharma tariffs call for Indian firms to reimagine drug exports. Act quickly

If the US is attempting to force localisation, India should respond aggressively with a proactive agenda. Here’s how.

On Camera

Violent class-war doctrines of Marx became the sole saviour of labour: MA Venkata Rao

It is not State aggrandisement that has to explain and justify itself but the claims of human liberty and individuality, libertarian commentator MA Venkata Rao wrote in 1958.

Indian economy to grow faster than expected at 7.6% in FY26, shows govt data under new series

Under new base year, FY2025-26 GDP growth revised up to 7.6 percent; Chief economic advisor revises growth for FY 2026-27.

India has ordered more Polish drones, Indian firm keen to set up munitions factory in Poland—Warsaw’s envoy

New Delhi: India is right to pursue and strike terrorists where they are, as during Op Sindoor, Poland’s Ambassador to India Dr Piotr Antoni...

Pakistan is fighting a two-front war. I saw it coming 15 yrs ago

The Pakistani political leadership is weak and devoid of any intellect. Its diplomacy is entirely India-China-US focused and suffers from a presumptive view of Afghanistan as a vassal.